Wordt geladen...
Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study
INTRODUCTION: In general, HIV co-infected patients included in clinical trials evaluating the hepatitis C virus (HCV) therapy with telaprevir (TVR) or boceprevir (BOC) with advanced fibrosis, are scarce. We analyze data concerning the use of these drugs in a real-life clinical setting with patients...
Bewaard in:
Gepubliceerd in: | J Int AIDS Soc |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
International AIDS Society
2014
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224840/ https://ncbi.nlm.nih.gov/pubmed/25394138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19634 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|